Naoko Takebe to Pilot Projects
This is a "connection" page, showing publications Naoko Takebe has written about Pilot Projects.
Connection Strength
0.069
-
The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study. J Natl Cancer Inst. 2021 01 04; 113(1):27-37.
Score: 0.041
-
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2015 Jun; 21(6):1083-90.
Score: 0.027